White Label vs Private Label vs Contract Manufacturing for Supplements

What is a white label supplement?

A white label supplement is a stock product, already formulated and manufactured, sold to any buyer who wants to put a name and logo on the bottle. The manufacturer builds one multivitamin, one collagen powder, one pre-workout blend, then resells it under dozens of different brand names with no change to the ingredient deck. You are buying the label, not the recipe.

Minimum order quantities on white label stock vary by three orders of magnitude depending on who you buy from. Supliful advertises a zero-unit minimum on its dropship catalog — order one bottle or a thousand, the platform charges the same either way. Makers Nutrition starts private-label stock formulas at 500 units, while SMP Nutra's own equipment imposes a hard floor of 1,000 bottles per SKU that cannot be split across products.

The catch with white label is that if the product you are copying is a specific competitor's offer rather than a generic catalog SKU, you cross into a different legal question — and where that line sits matters more than most buyers assume before they get a cease-and-desist letter.

How is private label different from white label?

Private label differs from white label in one dimension: customization of an existing base formula. A private-label buyer can usually adjust dosages, swap a flavor system, or add a single active to a manufacturer's stock formula without triggering the full R&D process of a from-scratch build — SMP Nutra prices this tier at $5 to $30 per unit against $4 to $20 for untouched stock, at the same 2,500-to-5,000-bottle standard MOQ.

Formula ownership does not track which of these two labels a manufacturer uses for its own marketing. Per Atrium Sci's comparison of contract manufacturing and private label supplements, the manufacturer owns the formula under a private-label arrangement by default, and the brand cannot port it to a competing manufacturer unless the contract says otherwise in writing.

Because that clause lives in the fine print rather than the sales page, the choice of manufacturer matters as much as the model — a comparison like Vox Nutrition against SMP Nutra is really a comparison of contract terms, not just catalogs.

When does full contract manufacturing make sense?

Full contract manufacturing makes sense once you need a formula that does not exist in any manufacturer's catalog and you are willing to pay to build and own it. This is the model for a genuinely novel stack, a proprietary blend ratio, or a delivery format no stock SKU offers — capsule, gummy, liquid or stick pack built to your specification from raw ingredients up.

That ownership carries a real bill before the first unit ships. Published setup ranges run $2,000 to $15,000 for formulation development, $3,000 to $8,000 for stability testing, $5,000 to $20,000 for tooling such as softgel molds or tablet dies, and $500 to $2,000 per batch for certificate-of-analysis testing, together adding roughly 20% to 40% on top of the quoted per-unit price. Not every manufacturer charges all of it; Superior Supplement Manufacturing states in its own FAQ that it charges no setup fees at all, which is one vendor's policy rather than an industry floor.

Whether you actually end up owning the finished formula depends entirely on what the development agreement says, not on which label — contract manufacturing, co-packing, private label — the vendor puts on the relationship; the mechanics of who owns the formula and who pays for a bad batch sit in the contract language, not in the category name.

Which model gets an offer to market fastest?

Stock white label gets an offer to market fastest, custom contract manufacturing slowest, with private label in between. Published lead times run 2 to 4 weeks for a stock formula, 4 to 8 weeks for a customized private-label build, and 8 to 16 weeks for a full custom formulation — and individual manufacturers publish tighter numbers still: SMP Nutra quotes 8 to 10 weeks for a new customer's first order and 6 to 8 weeks for reorders, while Superior Supplement Manufacturing states a private-label order can ship in 3 to 4 weeks.

The biggest cause of slippage is not line time but raw-material sourcing. Specialty or imported actives add weeks that an in-stock ingredient skips, compounded by the 21 CFR 111.75 requirement to identity-test every unique incoming lot, which adds a minimum of 5 to 10 days per lot regardless of formula complexity.

If speed to market matters more than owning a proprietary formula, a catalog that bundles the label with fulfillment removes an entire supply-chain step — ShipOffers' combined white-label-and-fulfillment model is one priced example of what that bundling actually costs versus building the stack yourself.

How do costs and MOQs compare across the three models?

Cost and MOQ move together, and the jump between models is not linear — it is roughly an order of magnitude at each step up. The table below lines up published pricing, per-format cost tiers, and published custom-formula MOQs by category.

Volume compresses per-unit cost inside every model, too. A standard 60-count capsule SKU with common ingredients is quoted at $3.50 to $4.50 per bottle at a 1,500-bottle run and $1.50 to $2.50 at 25,000 bottles, roughly half the per-unit cost from first-run MOQ to a 25,000-bottle commitment, before packaging or testing are added.

Packaging and testing are separate line items on top of the base quote, and they scale the same way. An 8 oz HDPE bottle with cap runs $0.66 each in a 48-count case versus $0.49 in a 280-count bulk case per Uline's list pricing, and a printed pressure-sensitive label drops from roughly $0.22 per unit at 500 pieces to $0.07 at 10,000-plus.

Can I start white label and move to a custom formula later?

Yes — starting on a stock formula and migrating to a custom build once volume justifies it is the standard bootstrap path, not a compromise. It lets you validate demand at a low MOQ before committing to the tenfold jump in commitment that a custom formula requires.

That jump is steep in gummies specifically: SMP Nutra lists stock gummy runs starting as low as 1,000 bottles, against 500,000 to 1,000,000 pieces — roughly 8,300 to 16,600 bottles at 60-count — for a custom gummy formula. Powders and capsules move less dramatically, but the same direction applies across every format.

Shelf life should factor into that migration decision, not just unit cost. Gummies run about a year of stability (up to two in optimal storage) and probiotics need real-time viability testing over 6 to 24 months, so committing to a large custom gummy run means sizing inventory in months of sell-through, not years, and formulators build 3% to 25% nutrient overage into the batch specifically to hold label claim through that window.

Which model do successful direct-response offers actually use?

Most successful direct-response supplement offers run on white label or lightly customized private-label stock, not on a proprietary formula built from scratch, which cuts against the industry's default sales pitch that a 'real brand' needs its own formula. Speed to test an angle, not formula novelty, is what determines whether a DR offer finds a winning ad before the account gets flagged; a stock SKU at a 2-to-4-week lead time lets an operator run five creative angles against one product while a custom build is still in stability testing.

Fulfillment economics reinforce the same bias toward stock formulas early. A 3PL like Fulfyld prices an average of $7.51 per order all-in, and Amazon's Multi-Channel Fulfillment charges $8.93 per unit for a single-unit large-standard order versus $4.70 per unit inside a 4-plus-unit order, a near-2x penalty that punishes low-volume testing regardless of whether the formula behind the offer is generic or proprietary.

None of that removes the compliance burden that scales with ad spend rather than with formula ownership. The disclaimer language, the claims substantiation, and platform-specific ad rules apply the same to a stock SKU as to a custom formula, and what TikTok actually allows in supplement ads is a separate risk surface from which manufacturing model you picked.

Quick decision checklist

Use this page as a decision aid, not a generic blog post. The practical question is whether the reader needs faster evidence about what is already working in VSL-driven direct response, especially across nutra, supplements, GLP-1, weight loss, blood sugar, and adjacent high-intent health markets.

Daily Intel Service is most relevant when the next decision depends on active market examples: which hook to test, which claim style is risky, which funnel structure is common, which language market is moving, and whether a competitor's creative is likely early, scaling, or already saturated.

• Start with the TL;DR if you need the direct answer.
• Use the table to compare trade-offs quickly.
• Use the FAQ for answer-engine-ready summaries.
• Use the CTA when the decision requires live VSL and ad examples instead of theory.

Daily Intel's coverage advantage

Daily Intel Service is positioned around category-leading variety and actionability: one of the broadest direct-response catalogs of VSLs and ad creatives across blackhat, greyhat, and whitehat advertising patterns, with enough context to understand what the advertiser is doing beyond the visible creative. The practical difference is that members are not just seeing a screenshot; they are seeing the VSL, the ad, the funnel path, the transcript, the UTM context, and the research notes that turn the asset into a decision.

This matters because direct-response affiliates do not operate in one clean category. A weight-loss campaign may use a whitehat compliance ad, a greyhat pre-lander, a more aggressive VSL, and a checkout path designed around upsells and recovery. A useful intelligence platform needs to capture that spectrum instead of pretending every winning campaign looks like a public brand ad.

Blackhat, whitehat, and multilingual signal coverage

Daily Intel tracks patterns across both blackhat-style and whitehat-style campaigns so operators can understand the market without blindly copying risk. Whitehat examples help with durability and compliance review; blackhat and greyhat examples reveal pressure points, hooks, mechanisms, and funnel structures that may be driving spend but require careful adaptation before use.

The catalog is also built for global operators, with VSL and ad references spanning 14+ languages and different local idioms. That is a key advantage for Brazilian, LATAM, European, MENA, Indian, and non-native English affiliates who need to see how the same market desire is translated across cultures instead of only studying US English ads.

How to use the intelligence responsibly

The goal is modeling, not copying. Use Daily Intel to understand structure: hook, mechanism, proof, claim intensity, funnel depth, offer economics, and saturation stage. Then build original creative, review claims, and adapt the angle to the traffic source, country, language, and compliance requirements of the campaign.

A strong workflow compares multiple examples before acting. If the same mechanism appears across several languages, several advertisers, and several funnel variants, it may be a durable market signal. If the example appears only once or depends on an aggressive claim, treat it as a research clue rather than a campaign template.

• Model structure, not protected creative assets.
• Separate whitehat durability from blackhat persuasion pressure.
• Compare US English examples against LATAM, European, and other language variants.
• Use transcripts and funnel notes to build original briefs.
• Keep compliance review separate from market research.

Methodology and source context

Daily Intel pages are written from a research workflow that reviews active VSLs, Meta ad creatives, transcripts, UTMs, funnel paths, checkout steps, upsells, recovery sequences, and compliance-sensitive claim patterns. The goal is to explain observable market behavior, not to provide legal, medical, or platform policy advice.

For educational pages, the supporting references should help readers verify search, crawlability, and public ad research context, especially Google helpful content guidance, Google SEO link best practices, and Meta Ad Library. Daily Intel then adds the direct-response interpretation layer so the page explains what the signal means for actual affiliate research decisions.

For deeper evaluation, continue through Daily Intel research methodology, Cost Per Result Goal on a Fixed-Payout Offer: Where to Set It, Value Optimization for Supplement Offers With Upsells and Rebills, Pausing Overnight, Weekends, and Between Tests: What It Costs, The Bottle Selector: Which Tier You Highlight and What It Costs You, and What is a VSL?. These related Daily Intel pages connect this topic to the relevant methodology, pricing, trust context, comparison path, or niche workflow.